drugset / Trial / NCT01001702
Oral Aripiprazole Open-Label Rollover Study
Parallel-groupOpen-labelTreatment
Summary
The purpose of this study is to test the long-term safety and tolerability of oral aripiprazole in adolescent patients with schizophrenia.
Timeline
- Start
- 2006-04
- Primary completion
- 2012-07
- Completion
- 2012-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aripiprazole | Other / unclassified | 5 mg | Oral |
| Subject | Aripiprazole | Other / unclassified | 30 mg | Oral |